Stay updated on EPX-100 Add-on Control in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page.
Latest updates to the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.3%
- Check22 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, and a notice regarding delays in study record information has been deleted.SummaryDifference4%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check44 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.3%
- Check65 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
- Check72 days agoChange DetectedA new study on EPX-100 (Clemizole Hydrochloride) for Dravet Syndrome has been added, while a previous study on its use as add-on therapy has been removed.SummaryDifference3%
Stay in the know with updates to EPX-100 Add-on Control in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPX-100 Add-on Control in Dravet Syndrome Clinical Trial page.